Publications - publikationer  (updated March 2016)

Section 1    no 1-12        Monographs
Section 2    no 13-214    Scientific publications,
Section 3    no 1-8          Ongoing studies 
Section 4    link to          Other written material (instructions, guidelines, comments etc)
Section 5    link to          Climate change blog (www.videnskab.dk)


References in each section listed according to year of publication

  1. 1. Monographs

  2. Lidegaard Ø. Oral contraceptives and cerebral thromboembolism. An epidemiological approach. Dissertation. Copenhagen, October 1996.

  3. Lidegaard Ø. Prize essay: 1. prize at the prize essay called by The Medical Association of Copenhagen. Title: "The role of doctors year 2000". Published 1986: "The future of health care" [da] in "The role of doctors, with special reference to Denmark", p 9-24, Lægeforeningens Forlag, Copenhagen 1986.

  4. Steensen JP, Andreasen PB, Lidegaard Ø (ed). Scientific methods for quality assurance in health care sector. [da] Danish Research Council, committee for primary health research and technology assessment and Danish Hospital Institute, November 1988.

  5. Lidegaard Ø. Report: "New educational technologies - a contribution for a solution of educational problems in health sector". [da] Danish Hospital Institute, DSI-Rapport 89.01, Copenhagen 1989.

  6. Lidegaard Ø, Weber T. Prize essay: 1. prize at the prize essay called by "Society of Young Gynaecologists". Title: "Gynaecology and obstetrics in Denmark year 2000". March 1990. Published by the Society October 1990.

  7. Lidegaard Ø, McNair P, Dirksen A (ed): Medical informatics in Denmark/Europe. [da] DSI-rapport 90.08, Copenhagen 1990.

  8. Lidegaard Ø, Looms P. Interactive media for teaching. CD-ROM, Laservision and interactive video. [da]. Directory of Copenhagen Hospitals, 1990.

  9. Lidegaard Ø, Steensen JP. Prize essay called by "Lundbeckfonden". Title: "Structure and financing of the Danish Health Care System in the nineties". [da] Published May 1992, Jurist og Økonomforbundets Forlag, 1992.

  10. Lidegaard Ø. "Women in menopause" [Da] . Kvinder i overgangsalderen. Danmarks Radio. ”Lægens bord”. DR-multimedie, november 2001.

  11. Lidegaard Ø. "Infertility. New knowledge - new options [Da]. Barnløshed. Nu viden – nye muligheder.  Danmarks Radio. ”Lægens bord”. DR-multimedie, oktober 2002.

  12. Lidegaard Ø, Hammerum M. "National Register of Patients as a tool of assessing clinical quality at Gynaecological departments [Da]. Landspatientregisteret til kvalitetssikring i det gynækologiske speciale. Sundhedsstyrelsen 2002. Pdf

2. Scientific publications (sorted after year of publication)

  1. Lidegaard Ø. Thrombo-embolic insults in the central nervous system and oral contraceptives. [Da]. Ugeskr Læger 1982; 144: 2769-72.

  2. Lidegaard Ø, Gyldensted C, Zeeberg I, Juhler M. Computer tomographic findings in acute multiple sclerosis. Acta Neurol Scand 1983; 68: 77-83.

  3. Lidegaard Ø, Boas J, Philip P. Primary affection of central nervous system at acute leukaemia. [da]. Ugeskr Læger 1983; 145: 3580-1.

  4. Lidegaard Ø, Jansen EC, Larsen TK. The influence of propranolol on the postural stability. Acta Neurol Scand 1984; 69: 412-16.

  5. Lidegaard Ø. Smoking habits among 15-44 year old women in 1983. [da]. Ugeskr Laeger 1984; 146: 3058-60.

  6. Lidegaard Ø. Use of oral contraceptives in 1983. [da]. Ugeskr Læger 1984; 146: 1172-4.

  7. Lidegaard Ø, Søe M, Andersen MVN. Cerebral thromboembolism among young women and men in Denmark 1977- 1982. Stroke 1986; 17: 670-5.

  8. Overgaard K, Hauch O, Lidegaard Ø. Deep venous thromboembolism and oral contraceptives. [da]. Ugeskr Laeger 1986; 148: 2348-50.

  9. Lidegaard Ø, Andersen MVN, Søe M. Cerebral thromboembolism, oral contraceptives and pregnancy. [da]. Ugeskr Laeger 1987; 149: 2135-7.

  10. Lidegaard Ø. Cerebrovascular deaths before and after the appearance of oral contraceptives. Acta Neurol Scand 1987; 75: 427-33.

  11. Lidegaard Ø, Overgaard K, Hauch O. The oral contraceptive user. Acta Obstet Gynecol Scand 1988; 67: 27-31.

  12. Lidegaard Ø. The future health care system. [da]. Månedsskr Prakt Laegegern 1988; 66: 7-15.

  13. Lidegaard Ø, Helm P. Sexual and reproductive life events in relation to duration of oral contraceptive use. Contraception 1988; 38: 69-77.

  14. Lidegaard Ø, Andreasen PB, Steensen JP. Quality assessment in health care system. [da]. Ugeskr Laeger 1989; 151: 924-7.

  15. Lidegaard Ø. New information technologies for teaching - also in the Danish health care sector? [da]. Ugeskr Læger 1989; 151: 1399-1402.

  16. Lidegaard Ø, Helm P, Kreiner S. Methods at research of sexual and contraceptive habits among 15-44 old women. [da]. Nord Sexol 1989; 7: 243-54.

  17. Lidegaard Ø. New information technologies for teaching - also in the Danish health care sector? [da]. Tidsskr for danske sygehuse 1989; 6: 195-9.

  18. Trap R, Helm P, Lidegaard Ø. Helm E. Premature rupture of the fetal membranes, the phases of the moon and barometer readings. Gynecol Obstet Invest 1989; 28: 14-8.

  19. Lidegaard Ø, Helm P. Sexual habits among 15-44 old women. [da]. Nord Sexol 1990; 8: 124-36.

  20. Lidegaard Ø, Helm P. Reproductive parameters and contraceptive habits among 15-54 year old women. [da]. Nord Sexol 1990; 8: 282-91.

  21. Lidegaard Ø, Danielsen O. New teaching technologies in primary health sector. [da]. Månedsskr Prakt Laegegern 1990; 68: 25-30.

  22. Lidegaard Ø, Helm P. Pelvic inflammatory disease: The influence of sexual, contraceptive, and social life events. Contraception 1990; 41: 475-83.

  23. Lidegaard Ø, Olsen O, Kristensen TS. Aetiology and prevention of diseases. Theory and practice. [da]. Nord Med 1990; 105: 87-90.

  24. Lidegaard Ø, Dirksen A, McNair P. Medical informatics. [da]. Ugeskr Laeger 1990; 152: 1149-51.

  25. Lidegaard Ø, Meinert L, Weber T. Birth technologies at Danish maternity units. [da] Ugeskr Laeger 1990; 152: 3702-5.

  26. Lidegaard Ø, Weber T. Gynaecology og obstetrics in Denmark year 2000. [da]. Ugeskr Laeger 1990: 152: 3107-13.

  27. Helm P, Lidegaard Ø. The relationship between menarche and sexual, contraceptive, and reproductive life events. Scand J Prim Health Care 1990; 8: 59-63.

  28. Lidegaard Ø. Medical informatics in Denmark/Europe. [da]. Ugeskr Læger 1991; 153: 593-4.

  29. Jensen LM, Jørgensen JS, Lidegaard Ø, Brinsden PR, Weber T. Spontaneous selective abortion of twin A with Down's syndrome followed by delivery of a normal twin B 14 weeks later. Eur J Obstet Gynecol Reprod Biol 1991: 42: 159-61.

  30. Lidegaard Ø, Meinert L, Weber T. Description, evaluation and clinical decision making according to different fetal heart rate patterns. Inter-observer and regional variability. Acta Obstet Gynecol Scand 1992; 71: 48-53. Pdf

  31. Lidegaard Ø, Jensen LM, Weber T. Description, evaluation and clinical decision making according to different fetal heart rate patterns. Inter-observer and regional variability. [Da] Ugeskr Laeger 1992; 71: 48-53.

  32. Madsen EM, Lidegaard Ø, Tabor A. Oophorectomy per occasionem and ovarian cancer. A survey. [da]. Ugeskr Laeger 1992.

  33. Lidegaard Ø. Oral contraception and risk of cerebral thromboembolic attacks: results of a case-control study. BMJ 1993; 306: 956-63. Pdf

  34. Lidegaard Ø. Postgraduate education of physicians. [Da] Ugeskr Laeger 1993; 155: 2485-9.

  35. Lidegaard Ø. Oral contraceptives and thrombosis. An update. [Da] Månedsskr Praktisk Laegegerning 1993; 71: 801-5.

  36. Lidegaard Ø. Oral contraceptives and cerebral thrombosis. [Da] Ugeskr Laeger 1993; 155: 3538-45. (Danish version of ref. 40).

  37. Lidegaard Ø. OC-use in Denmark 1980-1990 and smoking habits among fertile women in 1990. [Da] Ugeskr Laeger 1993; 3550-8.

  38. Lidegaard Ø. Research among Danish Doctors. [Da] Ugeskr Laeger 1993; 155: 3970-72.

  39. Lidegaard Ø. The influence from the technological development on the future structure of the Danish Health Care Sector. [Da] Ugeskr Laeger 1993; 155: 3622-3.

  40. Banfield P, Lidegaard Ø, Lange AK, Weber T. The obscare textbook. Concepts and principles of quality assurance and clinical audit in maternity services. WHO, October 1993.

  41. Madsen EM, Lidegaard Ø, Tabor A. Oophorectomy in the prevention of ovarian cancer. Acta Obstet Gynecol Scand 1993; 72: 599-600. Pdf

  42. Lidegaard Ø, Meinert L, Weber T. Technology use, Caesarean sections, and perinatal mortality at Danish Maternity Wards. Acta Obstet Gynecol Scand 1994; 73: 240-5. Pdf

  43. Lidegaard Ø. Cervical incompetence and cerclage in Denmark 1980-1990. An epidemiological survey. Acta Obstet Gynecol Scand 1994; 73: 35-8 . Pdf

  44. Lidegaard Ø, Krumpaszky HG, Roos JL, Johansen KS. European consensus conference on quality development indicators for perinatal care. Tübingen October 1993. WHO, Copenhagen November 1994.

  45. Lidegaard Ø. Cervical incompetence and cerclage in Denmark 1980-1990. (Da) Ugeskr Læger 1994; 156: 7200-2. Parallel publication to ref 53.

  46. Lidegaard Ø. Oral contraceptives and cerebral thrombosis. An epidemiological approach. In Creatsas G, Serfaty D, Skouby S (Ed): Proceedings of the 3rd Congress of the European Society of Contraception. Athens 1994, p 81-5.

  47. Lidegaard Ø. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynceol. 1995; 102: 153-9.

  48. Lidegaard Ø. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: An incidence study for the period 1980-1993. Contraception 1995; 52: 85-92. Pdf.

  49. Lidegaard Ø. Oral contraceptives and smoking, migraine, hypertension, diabetes, and previous thrombosis. A risk assessment with special reference to cerebral thromboembolism. Fertility Control Reviews 1995; 4: 14-5.

  50. Mosgaard B, Lidegaard Ø, Andersen AN. Use of fertility drugs in Denmark 1973-1993. Acta Obstet Gynaecol Scand 1995; 74: 614-8. Pdf

  51. Lidegaard Ø, Milsom I. The pill. The controversy continues. Acta Obstet Gynecol Scand 1996; 75: 93-7. Pdf

  52. Lidegaard Ø, Milsom I. Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies. Contraception 1996; 53: 135-9.

  53. Lidegaard Ø. Pill scare in profile. Global perspectives. Gynaecology Forum 1996; 1: 18-9.

  54. Lidegaard Ø. Decline in cerebral tromboembolism among young women after the introduction of low-dose oral contraceptives. Ugeskr Laeger 1996; 158: 5933-9. (parallelpubl. to ref. 59)

  55. Lidegaard Ø. Oral contraceptives and risk of arterial vascular disease. Gynecol Endocrinol 1996; 10 Suppl 2, 9-12.

  56. Lidegaard Ø. Oral contraceptives and venous thromboembolism: an epidemiological review. Eur J Contracep Reproduc Health Care 1996; 1: 13-20.

  57. Lidegaard Ø, Tabor A, Weber T, Loft A, Roos JL, Thomsen SG. Written patient information.. [da] Ugeskr Laeger 1996; 158: 2578-82.

  58. Lidegaard Ø. Oral contraceptives and migraine. In Hannaford PC, Webb AMC (Ed). Evidence-guided prescribing of the pill. Parthenon Publishing Group, London 1996; 299-306.

  59. Lidegaard Ø, Milsom I. Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies. Letter. Contraception 1996; 54: 195-8.

  60. Cretsas G, Pitsavos C, Amy JJ et al. A multicenter European survey of the attitudes to contraception in women at high risk or with established cardiocascular disease. Eur J Contracept Reprod Health Care 1996; 1: 267-73.

  61. Lidegaard Ø. Oral contraceptives and stroke. Issues and recommendations. CNS Drugs 1997; 7: 1-5.

  62. Lidegaard Ø. Oral contraceptives and cerebral thromboembolism. Acta Obstet Gynecol Scand 1997; Suppl. 164: 76: 66-68.

  63. Lidegaard Ø. The influence of thrombotic risk factors when oral contraceptives are prescribed. Acta Obstet Gynaecol Scand 1997; 76: 252-60. Pdf

  64. Lidegaard Ø. Tromboembolic complications by use of oral contraceptives. Editorial. Ugeskr Laeger 1997; 159; 1908-9.

  65. Lidegaard Ø, Milsom I. Oral contraceptives and venous thromboembolism. Lancet 1997, letter; 349: 1621.

  66. Lidegaard Ø. Oral contraceptives and stroke: Issues and recommendations. J Paediatrica, Obstetrics & Gynaecology 1997; 23: 5-7. (Parallel publ. to 72)

  67. Lidegaard Ø. Oral contraceptives and stroke: Issues and recommendations. J Practical Patient Care 1997; 26: 43-6. (Parallel publication to 72)

  68. Mosgaard BJ, Lidegaard Ø, Andersen AN. The impact of parity, infertility and treatment with fertility drugs on the risk of ovarian cancer. A survey. Acta Obstet Gynecol Scand 1997; 76: 89-95. Pdf

  69. Mosgaard BJ, Lidegaard Ø, Kjær SK, Schou G, Andersen AN. Infertility, fertility drugs and invasive ovarian cancer: A case-control study. Fertil Steril 1997; 67: 1005-12. Pdf.

  70. Loft A, Lidegaard Ø, Tabor A. Incidence of ovarian cancer after hysterectomy - a nationwide controlled follow up. Br J Obstet Gynecol 1997; 104: 1296-1301. Pdf

  71. Pedersen AT, Lidegaard Ø, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997; 350: 1277-83. Pdf.

  72. Milsom I, Odlind V, Hedberg C, Lidegaard Ø. Concern about increase in abortion rate [Swedish]. Läkartidningen 1997; 50: 4731-6.

  73. Lidegaard Ø, Kreiner S. Cerebral thrombosis and oral contraceptives. A case-control study. Contraception 1998; 57: 303-14. Pdf.

  74. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998; 57: 291-301. Pdf.

  75. Lidegaard Ø. Thrombotic diseases in young women and the influence of oral contraceptives. Am J Obstet Gynecol 1998; 179: S62-7. Pdf.

  76. Lidegaard Ø, Mikkelsen AL, Meldgaard M, Brøndum-Nielsen K, Lindenberg S. Severe male infertility. Impact of genetic factors on diagnosis and counselling. Acta Obstet Gynecol Scand 1998; 77: 799-803. Pdf

  77. Lidegaard Ø. Oral contraceptives and thrombosis [da]. Nordisk Medicin 1998; 113: 187-90.

  78. Bertelsen CA, Andreasson B, Lidegaard Ø. Oestrogen substitution to women treated for breast cancer [da]. Ugeskr Laeger 1998; 160: 6954-7.

  79. Mosgaard BJ, Lidegaard Ø, Kjær SK, Schou G, Andersen AN. Ovarian stimulation and borderline ovarian tumors. A case-control study. Fertil Steril 1998; 70: 1049-55. Pdf.

  80. Lidegaard Ø, Larsen JF. Early medical abortion. An update [da]. Ugeskr Laeger 1999, 161: 3275-7.

  81. Lidegaard Ø, Larsen JF, Blaabjerg J, Larsen E. The first 100 early medicical abortions. [da] Ugeskr Laeger 1999; 161: 3278-81.

  82. Lidegaard Ø, Bygdeman M, Milsom I, Nesheim B-I, Skjeldestad FE, Toivonen J. Oral contraceptives and thrombosis. From risk estimates to health impact. Acta Obstet Gynecol Scand 1999; 78: 142-9. Pdf

  83. Lidegaard Ø. Smoking and use of oral contraceptives. Impact on thrombotic diseases. Am J Obstet Gynecol 1999; 180: S357-63. Pdf.

  84. Lidegaard Ø. Oral contraceptives and myocardial infarction: reassuring new findings. Commentary. BMJ 1999; 518: 1583-4. Pdf.

  85. Parslov M, Lidegaard Ø, Klintorp S, Pedersen B, Jønsson L, Eriksen PS, Ottesen B. Risk factors among young women with endometrial cancer. A Danish case-control study. Am J Obstet Gynecol 2000; 182: 23-9. Pdf.

  86. Godsland IF, Winkler U, Lidegaard Ø, Crook D. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. Drug 2000: 60: 721-869.

  87. Lidegaard Ø. The risk of ischaemic stroke is increased in current users of oral contraceptives. Commentary. Evidence-based Obstet Gynecol 2000; 2: 74.

  88. Poulsen EF, Lidegaard Ø, Schiødt AV. Contraception in Denmark year 2000. [Danish]. Ugeskr Laeger 2000; 163; 4533-6.

  89. Lidegaard Ø, Schiødt AV, Poulsen EF. Oral contraceptives. General considerations. [Danish]. Ugeskr Laeger 2001; 163: 4544-6.pdf

  90. Lidegaard Ø, Poulsen EF, Schiødt AV. Oral contraceptives for women with special risk factors. [Danish]. Ugeskr Laeger 2001; 163: 4546-8.pdf

  91. Lidegaard Ø, Schiødt AV, Poulsen EF. Oral contraceptives and thrombosis. [Danish]. Ugeskr Laeger 2001; 163: 4549-53.pdf

  92. Lidegaard Ø. Spontaneous abortion. Editorial. [Danish] Ugeskr Laeger 2001; 163: 2121.

  93. Lidegaard Ø, Kreiner S. Oral contraceptives and cerebral thrombosis. A five-year National case-control study. Contraception 2002; 65: 197-205. Pdf.

  94. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptievs and venous thromboembolism. A five-year national case-control study. Contraception 2002; 65: 187-196. Pdf.

  95. Lidegaard Ø. Emergency contraception. [Da]. Nødprævention i håndkøb. Editorial. Ugeskr Laeger 2002; 164: 4999.

  96. Lidegaard Ø, Hammerum MS. National Registry of Patients as a tool in continuous production and quality control. [Da]. Ugeskr Laeger 2002; 164: 4420-3.

  97. Lidegaard Ø. Emergency contraception over the counter. Editorial. [Da] Ugeskr Laeger 2002; 164: 4999.

  98. Grønlund L, Grønlund A-L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Spontaneous abortion. Expectant management, medical treatment or surgical evacuation. Acta Obstetricia et Gynecologica 2002: 81: 781-2. Pdf.

  99. Grønlund A-L, Grønlund L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Management of missed abortion. Comparison of medical treatment with either mifepristone+misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen County, Denmark. Acta Obstetricia et Gynecologica 2002: 81; 1060-65. Pdf.

  100. Hammerum MS, Lidegaard Ø. Induced abortion at Gynaecological departments in Denmark 1999-2003. Www.tigrab.dk. 2002-2006.

  101. Hammerum MS, Lidegaard Ø. Spontaneous and missed abortions at Gynaecological Departments in Denmark 1999-2003.  Www.tigrab.dk. 2001-2006

  102. Lidegaard Ø. Absolute and attributable risk of venous thromboembolism in women on cyproterone acetate. J Obstet Gynaecol Canada 2003; 25: 575-7. Pdf.

  103. Lidegaard Ø, Utzon J, Nørgaard L, Møller TW. Clinical quality databases in Denmark year 2003. [Da]. Ugeskr Læger 2003; 165: 3737-40. Pdf.

  104. Lidegaard Ø. Hormonel patch contraception. [Da]. Ugeskr Laeger 2004; 166: 3591. Pdf

  105. Lidegaard Ø, Hammerum MS. Hysterectomies in Denmark 1998-2003. http://Www.dsog.dk. DSOG 2002-2004.

  106. Lidegaard Ø, Hammerum MS. Endometrial ablations at Gynaecological Departments in Denmark 1996-2003. [Da]. Www.dsog.dk/kvalitet. DSOG 2002-2004.

  107. Lidegaard Ø, Hammerum MS. Ectopic pregnancies in Denmark 1995-2003. http://Www.tigrab.dk. 1998-2006.

  108. Helm P, Lidegaard Ø. Sterilisations in Denmark 1996-2003. National follow-up. http://Www.dsog.dk. DSOG 2004.

  109. Lidegaard Ø, Jaszczak P. Quantification of ressources allocated to postgraduate education of doctors.  [Da] (Kvantificering af resurser allokeret til lægelig videreuddannelse). Ugeskr Laeger 2004; 166: 2037-40. Pdf

  110. Lidegaard Ø, Kroman N. The epidemiology of breast cancer. Eur Clin Obstet Gynaecol 2005; 1: 24-8. Pdf.

  111. Lidegaard Ø, Pinborg A, Andersen AN. Imprinting diseases and IVF. Danish National IVF cohort study. Hum Reprod 2005; 20: 950-4. Pdf.

  112. Lidegaard Ø, Poulsen EF. Contraception [Da]. In Ottesen B, Mogensen O, Forman A (Ed): Gynaecology [Da]. Munksgaard, Copenhagen 2005; 3: 106-24.

  113. Secher LL, Klysner AH, Lidegaard Ø. Treatment of ectopic pregnancies in Denmark. [Da]. Ugeskr Laeger 2005; 167: 2048-50. Pdf

  114. Pinborg A, Lidegaard Ø, Freiesleben NLC, Andersen AN. Consequences of vanishing twins in IVF/ICSI pregnancies. Hum Reprod 2005; 20: 2821-9. Pdf

  115. Kroman N, Lidegaard Ø, Kvistgaard ME. Breast cancer - an acquired disease? [Da] Mammacancer - en livsstilssygdom?. Ugeskr Laeger 2005; 167: 4636-41.Pdf

  116. Lidegaard Ø, Pinborg A, Andersen AN. Imprinting disorders after assisted reproductive technologies. Curr Opin Obstet Gynecol 2006; 18: 293-6. Pdf.

  117. Pinborg A, Lidegaard Ø, Andersen AN. The vanishing twin - a major determinant of infant outcome in IVF singletons. Br J Hosp Med 2006; 67: 417-20.

  118. Lidegaard Ø. Gynaecological epidemiology [Danish]. Ugeskr Laeger 2006; 168; 3806-8. pdf

  119. Lidegaard Ø, Hansen NF. De novo development of dyspnoea in a young healthy woman with fatal outcome. [Danish]. Ugeskr Laeger 2007; 169: 2032-3. pdf.

  120. Lynge, E, Rostgaard K, Kroman N, Lidegaard Ø, Kvistgaard ME. Descriptive epidemiology: Trend in incidence of breast cancer by time, geographical and social differences, risk factors, etc. [Danish]. Ugeskr Laeger 2007: 169: 2965-7. Pdf.

  121. Pinborg A, Lidegaard Ø, Freiesleben NLC, Andersen AN. Vanishing twins: a predictor of small-for-gestational age in IVF singletons. Hum Reprod 2007; 22: 2707-14. Pdf

  122. Løkkegaard E, Lidegaard Ø, Møller LN, Agger C, Andreasen AH, Jørgensen T. Hormone replacement therapy in Denmark 1995-2004. Acta Obstet Gynaecol 2007; 86: 1342-51.pdf

  123. Lidegaard Ø, Svendsen AL. Sexual habits before multiple sclerosis. A National case-control study. Multiple Sclerosis 2008; 14: 73-80. pdf

  124. Lidegaard Ø. Oral contraceptives: 40 years after release. Acta Obstetricia Gynecologica 2008; 87: 4-5. pdf

  125. Lidegaard Ø, Lidegaard M. Global climate: The sick patient [Danish] Klodens klima: den syge patient. Ugeskr Laeger 2008; 170: 2663-6. Pdf

  126. Lidegaard M, Lidegaard Ø. Global climate: The curative therapy. [Danish] Klodens klima: Den kurative terapi. Ugeskr Laeger 2008; 170: 2714-7. Pdf. 

  127. Løkkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard Ø. Hormone therapy and risk of myocardial infarction. A National registry study. Eur Heart J 2008; 29: 2660-8. Pdf

  128. Lidegaard Ø. National Registry of Patients - again. [Danish] Landspatientregisteret - igen. Editorial. Ugeskr Laeger 2009: 171: 397. Pdf.

  129. Petri AL, Høgdall C, Lidegaard Ø. Diagnosis of primary ovarian cancer in Denmark [Danish]. Diagnoseregistrering af primær ovariecancer i Danmark. Ugeskr Laeger 2009; 171: 408-11. Pdf.

  130. Lidegaard Ø, Vestergaard CHF, Hammerum MS. Quality assessment based on registry data [Danish]. Kvalitetsmonitorering ud fra data i Landspatientregisteret. Ugeskr Laeger 2009; 171: 412-5. Pdf.

  131. Forstholm MM, Lidegaard Ø. Maternal request in Denmark 2001-2006. [Danish]. Ugeskr Laeger 2009; 171: 497-502. Pdf

  132. Vestergaard CHF, Lidegaard Ø, Tabor A. Invasive prenatal diagnostic practice in Denmark 1996-2006. Acta Obstet Gynecol Scand 2009; 88: 362-5. Pdf

  133. Lidegaard Ø. Sea level and CO2. Lessons from the past. Climate Change: Global Risks, Challenges and Decisions 2009. doi:10.1088/1755-1307/6/7/072038. Pdf. Climate conference poster: pdf

  134. Tabor A, Vestergaard CHF, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis. An 11-year national registry study. Ultrasound in Obstetrics and Gynecology 2009; 34: 19-24. pdf

  135. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism. A National follow-up study. BMJ 2009; 339: b2890 pdf

  136. Mørch LS, Løkkegaard E, Andreasen AH, Kjær SK, Lidegaard Ø. Hormone therapy and ovarian cancer. A National Cohort study. JAMA 2009; 302: 298-305. pdf

  137. Lidegaard Ø, Ricketts MN. Climate change and health care. Seminar of the World Medical Association. Danish Medical Association, Copenhagen 2009. pdf

  138. Lidegaard Ø. Lifestyle and climate change [Danish]. Ugeskr Laeger 2009; 171: 3194-7. pdf

  139. Færgeman O, Lidegaard Ø. Climate and health [Danish]. Ugeskr Laeger 2009; 171: 3163. pdf

  140. Lidegaard Ø. Climate and health. Acta Obstet Gynecol 2009; 88: 1305-6. pdf

  141. Moeller LBK, Moeller C, Thomsen SG, Andersen LF, Lundvall L, Lidegaard Ø, Kjer JJ, Ingemanssen JL, Zobbe V, Floridon C, Petersen J, Ottesen B. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial. Acta Obstet Gynecol Scand. 2009; 88:1331-7. pdf

  142. Forstholm MM, Langhoff-Roos J, Lidegaard Ø. Maternal request among primiparous. A case-control study. [Danish]. Ugeskr Laeger 2010; 172: 2075-9. pdf.

  143. Lykke JA, Dideriksen KL, Lidegaard Ø, Langhoff.Roos J. First trimester vaginal bleeding and complications later in pregnancy. Obstet Gynecol 2010; 115: 935-42. pdf

  144. Nielsen HS, Steffensen R, Lund M, Egestad L, Mortensen LH, Andersen AM, Lidegaard Ø, Christiansen OB. Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum Reprod 2010; 25: 1543-52. pdf

  145. Lidegaard Ø. Critique of a Danish cohort study on hormonal contraception and VTE. J Fam Plann Reprod Health Care 2010; 36: 103-4. pdf

  146. Lidegaard Ø. Early pregnancy and abortion. Annual report for 2009. National clinical quality database. [Danish] Tigrab-KD. www.tigrab.dk.

2011

  1. Munk-Olsen T, Laursen TM, Pedersen CB, Lidegaard Ø, Mortensen PB. Induced first-trimester abortion and risk of mental disorder. NEJM 2011; 364; 332-9. pdf.

  2. Virkus RA, Løkkegaard ECL, Bergholt T, Mogensen U, Langhoff-Roos, Lidegaard Ø. Venous thromboembolism in pregnant and puerperal women. A national cohort study. Thrombosis and Haemostasis 2011; 106: 304-9. pdf

  3. Nielsen SL, Daugbjerg SB, Gimbel H, Settnes A; Steering Committee of Danish Hysterectomy Database. Use of vaginal hysterectomy in Denmark: rates, indications and patient characteristics. Acta Obstet Gynecol Scand. 2011; 90: 978-84. Pdf

  4. Settnes A, Lykkebo A, Eriksen G, Lidegaard Ø, Sørensen JL. Successful training course in academic research in gynaecology and obstetrics. [Danish]. Ugeskr Laeger. 2011; 173: 1427-9. pdf

  5. Henningsen AK, Romundstad LB, Gissler M, Nygren KG, Lidegaard O, Skjaerven R, Tiitinen A, Andersen AN, Wennerholm UB, Pinborg A. Infant and maternal health monitoring using a combined Nordic database on ART and safety. Acta Obstet Gynecol Scand. 2011; 90: 683-91. pdf

  6. Henningsen AK, Pinborg A, Lidegaard Ø, Vestergaard C, Forman JL, Andersen AN. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril. 2011; 95: 959-63.

  7. Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011; 343: d6423.

  8. Lidegaard Ø. Epidemiologic research using administrative databases: garbage in, garbage out. Obstet Gynecol. 2011; 117: 410-1.

  9. Lidegaard Ø. Reply to Jürgen Dinger and Samuel Shapiro. BMJ 2011; online December 12, 2011.

  10. Lidegaard Ø. Early pregnancy and abortion. Annual report for 2010. National clinical quality database. [Danish] Tigrab-KD. www.tigrab.dk.

  11. Lidegaard Ø. Fertilitet, menstruation, kontraception og polycystisk ovariesyndrom. [Danish]. In Eds. Svendsen OPL, Astrup A, Hansen GS. Adipositas. Sygdom, behandling og organisation. Munksgaard, København 2011.

2012

  1. Lund M, Kamper-Jørgensen M, Nielsen HS, Lidegaard O, Andersen AM, Christiansen OB. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol. 2012; 119: 37-43. pdf

  2. Mørch LS, Løkkegaard E, Andreasen AH, Kjær SK, Lidegaard O. Hormone therapy and ovarian borderline tumors: a national cohort study. Cancer Causes Control. 2012; 23: 113-20. pdf

  3. Mørch LS, Løkkegaard E, Andreasen AH, Kjær SK, Lidegaard O. Hormone therapy and different ovarian cancers: A National cohort study. Am J Epidemiol 2012; 175: 1234-42 pdf

  4. Lidegaard Ø, Nielsen LH, Skovlund CW, Løkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10, BMJ 2012;344:e2990. pdf

  5. Wilson NM, Laursen M, Lidegaard Ø. Oral contraception in Denmark 1998-2010. Acta Obstet Gynecol Scand 2012; Apr 9. doi: 10.1111/j.1600-0412.2012.01416.x pdf

  6. Nørgaard LN, Pinborg A, Lidegaard Ø, Bergholt T. A Danish national cohort study on neonatal outcome in singleton pregnancies with placenta previa. Acta Obstet Gynecol Scand 2012; 91: 546-51. pdf

  7. Munk-Olsen T, Laursen TM, Pedersen CB, Lidegaard Ø, Mortensen PB. First-time first-trimester induced abortion and risk of re-admission to a psychiatric hospital in women with a history of treated mental disorder. Arch Gen Psychiatry 2012; 69: 159-65. pdf

  8. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366: 2257-66  pdf

  9. Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE. Hormonal contraception and venous thrombosis. Acta Obstet Gynecol Scand 2012; 91: 769-78  pdf

  10. Lidegaard Ø. Early pregnancy and abortion. Annual report for 2011. National clinical quality database. [Danish] Tigrab-KD 2012. www.tigrab.dk. pdf

  11. Bentzen JG, forman JL, Pinborg A, Lidegaard Ø, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online 2012; 25: 612-9. pdf

  12. Lidegaard Ø. Early pregnancy and abortion. A clinical quality database. [Danish]. Ugeskr Laeger 2012; 174: 2531. pdf

2013

  1. Lidegaard Ø. Hormonal contraception and venous thromboembolic risk in midlife women. Editorial. Maturitas 2013; 74: 1-2  pdf.

  2. Kårhus LL, Egerup P, Skovlund CW, Lidegaard Ø. Long-term reproductive outcomes in women whose first pregnancy is ectopic. A National controlled follow-up study. Human Reproduction 2013; 28: 241-6. pdf

  3. Jensen HM, Grøn R, Lidegaard Ø, Pedersen LH, Andersen PK, Kessing LV. Maternal depression, antidepressant use in pregnancy and Apgar scores in infants. Br J Psychiatry 2013; 202: 347-51. pdf

  4. Dalsgaard T, Hansen MVH, Hartwell D, Lidegaard Ø. Reproductive prognosis in daughters of women with and without endometriosis. Hum Reprod 2013; Advance access, May 21, 2013. pdf

  5. Lidegaard Ø. Hormonal contraception and venous thrombosis. Editorial. [Danish]. Ugeskr Laeger 2013; 175: 1401. pdf

  6. Sperling C, Noer MC, Christensen IJ, Nielsen ML, Lidegaard Ø, Høgdall C. Comorbidity is an independent prognostic factor for the survival of ovarian cancer: A Danish register-based cohort study from a clinical database. Gynecol Oncol 2013: 129: 97-102. pdf

  7. Jensen HM, Grøn R, Lidegaard Ø, Pedersen LH, Andersen PK, Kessing LV. The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age. Psychopharmacology 2013; epub ahead of print. pdf

  8. Guldberg R, Wehberg S, Skovlund SW, Mogensen O, Lidegaard Ø. Salpingectomy as standard at hysterectomy? A Danish cohort study 1977-2010. BMJ Open 2013; 3: e002845. doi:10.1136/bmjopen-2013-002845. pdf

  9. Virkus RA, Løkkegaard EC, Lidegaard Ø, Langhoff-Roos J, Bjerregaard L, Skovlund CW, Bergholt T. Venous thromboembolism in pregnancy and the puerperal period: a study of 1210 events. Acta Obstet Gynecol Scand 2013; 92: 1135-42. pdf

    2014
     

  10. Svovlgaard O, Lidegaard O, Nielsen ML, NEdergaard L, Mosgaard BJ, Lidang M, Mogensen O, Kock K, Blaakaer J, Staehr E, Andersen ES, Grove A, Høgdall C. Lymphadenectomy in surgical state I epithelial ovarian cancer. Acta Obstet Gynecol Scand 2014; 93: 256-60. pdf

  11. Noer MC, Sperling C, Christensen IJ, Nielsen ML, Lidegaard Ø, Høgdall C. Comorbidity is an independent prognostic factor in women with uterine corpus cancer: a nationwide cohort study. Acta Obstet Gynecol Scand 2014; 93: 325-34. pdf

  12. Kårhus LL, Egerup P, Skovlund CW, Lidegaard Ø. Impact of ectopic pregnancy for reproductive prognosis in next generation. Acta Obstet Gynecol Scand 2014; 93: 416-9 pdf

  13. Henningsen AA, Wennerholm UB, Gissler M, Romundstad LB, Nygren KG, Tiitinen A, Skjaerven R, Nyboe Andersen A, Lidegaard Ø, Forman JL, Pinborg A. Risk of stillbirth and infant deaths after assisted reproductive technology: a Nordic study from the CoNARTaS group. Hum Reprod 2014; 29: 1090-6. pdf

  14. Berlac JF, Skovlund CW, Lidegaard Ø. Ostetrical and neonatal outcomes in women following gastric bypass: a Danish national cohort study. Acta Obstet Gynecol Scand 2014; 93: 447-53. pdf

  15. Hjordt Hansen MC, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard Ø. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand 2014; 93: 483-9. pdf

  16. Egerup P, Kårhus LL, Skovlund CW, Lidegaard Ø. Improving reproductive long-term prognosis for women with a first ectopic pregnancy: a national controlled follow-up study. Acta Obstet Gynecol Scand 2014; 93: 490-6. pdf

  17. Virkus RA, Løkkegaard E, Lidegaard Ø, Lanfhoff-Roos J, Nielsen AK, Rothman KJ, Bergholt T. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PLoS One 2014; 9: doi: 10.1371/journal.pone.0096495. pdf

  18. Lidegaard Ø. Hormonal contraception, thrombosis and age. Expert opinion. Drug Safety 2014; 13: 1353-60 pdf

  19. Hedegaard M, Lidegaard Ø, Hedegaard M. Reduction in stillbirths at term after new birth induction paradigm: Results of a national intervention. BMJ open 2014;4:e005785.doi:10.1136/bmjopen-2014-005785. pdf

  20. Lidegaard Ø. The INAS-OC study. Letter. Contraception 2014;  doi: 10.1016/j.contraception.2014.08.012. pdf

  21. Berlac JF1Hartwell DLanghoff-Roos JLidegaard O. Endometriosis and obstetrical complications [Article in Danish]. Ugeskr Laeger. 2014; 176. pii: V01140004.pdf.

  22. Berlac JF, Langhoff-Roos J, Lidegaard O, Hartwell D. Severe intraabdominal bleeding in a pregnant woman with a history of endometriosis [Article in Danish Ugeskr¨Laeger. 2014;176. pii: V04140247. Pdf.

  23. Henningsen AK, Wennerholm UB, Gissler M, Romundstad LB, Nygren KG, Tiitinen A, Skjaerven R, Andersen AN, Lidegaard Ø, Forman JL, Pinborg A. Implication of the liberal use of ART in Nordic countries: should stricter guidelines be created to prevent unnecessary stillbirth and preterm delivery? Hum Reprod. 2014 Nov;29(11):2600-1. doi: 10.1093/humrep/deu244. Epub 2014 Sep 29. Pdf.

  24. Fussing-Clausen C, Geirsson RT, Hansen T, Rasmussen S, Lidegaard Ø, Hedegaard M. Mode of delivery and subsequent reproductive patterns. A national follow-up study. Acta Obstet Gynecol Scand 2014;Oct;93(10):1034-41. doi: 10.1111/aogs.12469. Pdf.

          Lidegaard Ø. Hormonal contraception and venous thromboembolism. Many myths are still being advanced. Contraception 2014; declined pdf.

2015

  1. .Hedegaard M, Lidegaard Ø, Skovlund C, Mørch L, Hedegaard M. Perinatal outcomes following an earlier post-term labour induction policy: a historical cohort study. BJOG. 2015 Feb 18. doi: 10.1111/1471-0528.13299. pdf.

  2. Henningsen AA, Gissler M, Skjaerven R, Bergh C, Tiitinen A, Romundstad LB, Wennerholm UB, Lidegaard O, Nyboe Andersen A, Forman JL, Pinborg A. Trends in perinatal health after assisted reproduction: a Nordic study from the CoNARTaS group. Hum Reprod. 2015; 30:710-6. doi: 10.1093/humrep/deu345. Epub 2015 Jan 20. Pdf.

  3. Honorato TC, Henningsen AA, Haadsma ML, Land JA, Pinborg A,Lidegaard Ø, Groen H, Hoek A. Follicle pool, ovarian surgery and the risk for a subsequent trisomic pregnancy. Hum Reprod. 2015 Mar;30(3):717-22. doi: 10.1093/humrep/deu357. Epub 2015 Jan 12. Pdf.

  4.  Larsen ML, Hilden M, Lidegaard Ø. Sexual assault: a descriptive study of 2500 female victims over a 10-year period. BJOG. 2015 Mar;122(4):577-84. doi: 10.1111/1471-0528.13093. Epub 2014 Oct 15. Pdf.

  5.  

  6. Lidegaard Ø. The risk of arterial thrombosis increases with the use of combined oral contraceptives. Evidence Based Medicine 2015;
    10.1136/ebmed-2015-110303. pdf
  7.  Matthesen T, Rasmussen AMO, Nielsen LH, Lidegaard Ø. Polycystic ovary syndrome, hormonal contraception and thrombotic stroke. A historical cohort study. J Neurol Disord Stroke 2015; 3: 1101-8. pdf

  8. Meaidi A, Goukasian I, Lidegaard O. Use of vaginal estrogen in Danish women: a nationwide sross-sectional study. Acta Obstet Gynecol Scand 2015; DOI: 10.1111/aogs.12833. pdf

  9. Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard Ø, Demeestere I, Azim HA. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. Eur J Cancer 2015; 51: 1490-6. pdf

  10. Lidegaard Ø, Matthesen T. Pas på de nye online tidsskrifter. [in Danish] Ugeskr Laeger 2015; pdf

2016

 

 

Pending studies

  1. Helm P, Lidegaard Ø, Vestergaard CHF. Unintended pregnancies following female sterilisation. A National follow-up of 58,240 unselected sterilisations.

  2. Lidegaard Ø, Vestergaard CHF, Hammerum M, Dziegiel MH, Poulsen D, Johansson PI, Titlestad K, Johnsen SP, Svendsen AL. Severe haemorrhage after medically and surgically induced abortion.

  3. Lidegaard Ø, Løkkegaard E, Møller LN, Agger C, Andreasen AH. A National register study on breast cancer risk with hormone therapy in Danish women. Part 1. Main results on hormone regimens in postmenopausal women.

  4. Lidegaard Ø, Løkkegaard E, Møller LN, Agger C, Andreasen AH. Hormone therapy and breast cancer. A National follow-up of Danish women. Part II. Route of administration, estrogen dose and progestagen type.

  5. Dideriksen KL, Lykke JA, Langhoff-Roos J, Lidegaard Ø. The predictive value of bleeding in early pregnancy for postnatal morbidity in the offspring. A National follow-up study.